Ewingella americana is a very rare cause of serious infections, especially in immunocompromised patients. We report a case of ventilator-associated pneumonia (VAP) in an intensive care unit patient, who was treated successfully with ceftriaxone. To the best of our knowledge, this is the first case of VAP due to Ewingella americana in the English literature.
INTRODUCTION
Ewingella americana, which belongs to the Enterobacteriaceae family, is an extremely rare cause of nosocomial bacteremia, peritonitis associated with peritoneal dialysis, and conjunctivitis. 1 Pneumonia caused by Ewingella americana were also reported in an outpatient. 2 and in an intensive care unit (ICU) patient. 3 Here, we report a case of ventilatorassociated pneumonia (VAP); to the best of our knowledge, this is the first such case of VAP due to Ewingella americana to be reported in the English literature.
CASE
A 55 year old, Caucasian, male patient, who were diagnosed as myasthenia gravis five months previously, was admitted to the University Hospital of Kırıkkale, Turkey with insomnia and shortness of breath. Thirty minutes after admission, he developed cardiopulmonary arrest due to the involvement of respiratory muscles. The patient responded to the cardiopulmonary resuscitation, and after endotracheal intubation, he was transferred to the ICU. At the admission, the patient did not have any physical or laboratory findings of infection. On the third day of admission, he developed fever and dyspnea. Purulent tracheal secretions were observed. On the physical examination, body temperature was 38.7°C, heart rate 102/min, respiratory rate 26/min and arterial blood pressure 110/70 mmHg. Physical examinations were unremarkable except crepitant crackles on the right lower zone of the lung. Laboratory findings revealed; 6.300 leukocytes/mm³ (86% neutrophils), platelets 170.000 / mm³, hemoglobin 11.4 g/dL, C-reactive protein 66 mg/L (reference range 0-5 mg/L) and normal hepatic and renal functions.
The postero-anterior chest X-ray showed infiltration at the right lower zone. The patient was diag- nosed as VAP. After blood, urine and tracheal aspirate cultures were obtained, the patient was treated empirically with meropenem (1 g every 8 hours) regarding to the antibiotic susceptibility pattern in the ICU. Tracheal aspirate culture revealed 1.000.000 cfu/ml non-hemolytic Gram-negative bacilli on blood agar plate and lactose-negative colonies on eosine methylene blue (EMB) agar plate after 24 hours incubation at 37°C. The isolate was identified as Ewingella americana by VITEK 2 automated system. Urine and blood cultures did not reveal any bacterial growth which were obtained during the initiation of antibacterial therapy. The strain was susceptible to ampicillin, amoxicillin/clavulanate, piperacillin/ tazobactam, cefuroxime, cefoxitin, cefixime, ceftazidime, ceftriaxone, cefoperazone/sulbactam, ertapenem, imipenem, meropenem, amikacin, gentamicin, ciprofloxacin, trimethoprim /sulfamethoxazole. According to the antibiotic susceptibility pattern of the isolated bacteria, the meropenem therapy was deescalated to ceftriaxone (1 g every 12 hours). On the second day of antibiotherapy, the patient defervesced, and the inflammation markers (C-reactive protein) declined. His antibiotic treatment was continued for 10 days. At the end of antibiotherapy the patient was still intubated due to his underlying condition, but he had no signs or symptoms of infection.
DISCUSSION
Ewingella americana was first described by Grimont and coworkers in 1983. 4 It is a rare bacteria with low pathogenic potential and usually effects immunocompromised patients. 2 It can cause peritonitis, conjunctivitis, pneumonia, bacteremia and sepsis. 2, [5] [6] [7] [8] [9] A patient who died due to Waterhouse-Friderichsen syndrome, showed growth of Ewingella americana in the postmortem bacteriologic cultures, which shows the pathogenic potential of this bacteria. 10 It may colonize in wounds and sputum without causing clinical infection. 2, 11 Sputum was reported as the most common isolation sample and bacteremia as the most common infections due to Ewingella Americana. Ventilator-associated pneumonia (VAP) is an infection that occurs in an ICU patient more than 48 hours after endotracheal intubation and mechanical ventilation. VAP remains a significant cause of patient morbidity and mortality. 12 Only one pneumonia case in an ICU patient caused by Ewingella americana has been reported to date, but this case was not defined as VAP.
3 To our knowledge, our case is the first to be defined as VAP in the English literature. The strain was identified with VITEK-2 automated system and with this automatized system, more than %98 of the isolates can be correctly identified to the species level without any requirement of further testing. 13 Reported sources of infections have been identified as catheters, contaminated ice bath used in cardiovascular surgery and the hands of healthcare workers. 8, 14 Additionally, Ewingella americana caused an outbreak of pseudobacteremia owing to cross contamination of blood culture bottles with non-sterile blood collection tubes. 6 In the present case, we carried out an extensive search to determine the source of infection. Hands and nasal cavities of the health-care workers who cared with the patient, the environment of the patient including the ventilation system, and the water circuit in the patient room were examined but the source of infection could not be identified.
Although Ewingella americana is generally susceptible to antibiotics, it can sometimes be multidrug resistant.
3,5,15 Our patient's isolate was susceptible to all antibiotics tested.
